More than five decades on, the battle for justice over birth defects caused by the drug thalidomide continues in only one European country: Spain. Spanish victims of thalidomide are the only ones ...

Along with its conventional role in patients with newly diagnosed and relapsed multiple myeloma, thalidomide has also been evaluated as maintenance therapy following ASCT. From a biological standpoint ...

BERLIN – 1946 — Gruenenthal, a German pharmaceutical, is founded in Stolberg. 1954 — Gruenenthal discovers and patents thalidomide. 1957 — Thalidomide is first sold as Contergan in Germany. It is ...

A study by Goethe University Frankfurt points to the possibility that thalidomide derivatives are potentially suitable for treating cancer. Thalidomide was marketed in the 1950s as a sleeping pill. It ...

Thalidomide is a medication with several different effects, one of which is promoting sleep in the context of insomnia. In a new study, researchers from the University of Tsukuba have discovered that ...

The primary objectives were to assess the feasibility and toxicities of thalidomide maintenance therapy following autologous peripheral stem cell transplantation and to evaluate the CR rate. The ...

The German manufacturer of a notorious drug that caused thousands of babies to be born with shortened arms and legs, or no limbs at all, issued its first ever apology Friday - 50 years after pulling ...

While thalidomide was responsible for tens of thousands of deformed babies in Europe in the late 1950s and early 60s, decades later data is showing the drug to be efficacious against certain chronic ...

Nearly 50 years ago, an increasing number of babies worldwide were born with deformities and missing limbs. The babies had fallen victim to the teratogenic effects of thalidomide, a drug commonly ...

Scientists have studied thalidomide's target protein, cereblon (CRBN), and its binding protein, AMP-activated protein kinase (AMPK), which plays an important role in maintaining intracellular energy ...

Editor’s Note: Geoff Adams-Spink was born in 1962 with multiple impairments caused by the drug, thalidomide. He was a BBC journalist for 22 years, and latterly the Age and Disability Correspondent. He ...